Cat. No. | Product name | CAS No. |
DC22051 |
CDD-450
CDD-450 is an unique inhibitor that selectively blocks p38α activation of proinflammatory kinase MAPK-MK2 while sparing p38α activation of PRAK and ATF2. |
|
DC8361 |
CDDO(Bardoxolone; RTA 401)
Featured
CDDO is a synthetic oleanane triterpenoid that blocks the cellular synthesis of inducible nitric oxide synthase and inducible COX-2 in INF-γ-activated mouse macrophages with an IC50 value of 0.4 nM. |
218600-44-3 |
DC12026 |
CDDO-2P-Imidazolide
Featured
CDDO-2P-Im is a new analogue of CDDO-Imidazolid,showing better bioactive than CDDO-Imidazolid. |
1883650-96-1 |
DC12027 |
CDDO-3P-Imidazolide
Featured
CDDO-3P-Im is a new analogue of CDDO-Imidazolid,showing better bioactive than CDDO-Imidazolid. |
1883650-95-0 |
DC20334 |
CDK2 inhibitor 73
Featured
CDK2 inhibitor 73 is a potent, selective CDK2 inhibitor with IC50 of 44 nM for CDK2/cyclin A, displays 2,000-fold selectivity over CDK1/cyclin B (IC50=86 uM).. |
2079895-42-2 |
DC20921 |
CDK5 inhibitor 20-223
CDK5 inhibitor 20-223 (CP 668863) potent, selective, ATP-competitive CDK2/5 inhibitor with IC50 of 6.0 and 8.8 nM for CDK2/CyclinE and CDK5/p35, with little to no activity against CDK1/4/6/7/9. |
865317-30-2 |
DC12528 |
CDK9 inhibitor HH1
CDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor.. |
204188-41-0 |
DC20335 |
CDK9-IN-8
Featured
CDK9-IN-8 is a highly potent, selective CDK9 inhibitor with IC50 of 12 nM, shows good selectivity in CDKs kinase profiling assay against CDK kinases and cell proliferation inhibition. |
2105956-51-0 |
DC23138 |
CDK-I73
Featured
CDKI-73 is a potent CDK9 inhibitor with Ki of 4 nM, shows cytotoxicity against a broad CLL samples with mean LD50 of 80 nM. |
1421693-22-2 |
DC11393 |
CDM-NAG
Featured
CDM-NAG is a useful tool compound to deliver the siRNA. |
1299292-01-5 |
DC20879 |
CDP-840
CDP-840 (CDP840. |
162542-90-7 |
DC20880 |
CDP-840 hydrochloride
CDP-840 (CDP840. |
|
DC23463 |
CDPPB
Featured
CDPPB is a potent, selective, brain penetrant positive allosteric modulator of mGlu5 receptor with EC50 of 10 nM and 20 nM for human and rat mGluR5, respectively. |
781652-57-1 |
DC22446 |
CE-224535
CE-224535 (PF-04905428) is a potent and selective P2X7 receptor antagonist with IC50 of 1.4 nM (inhibition of the release of lL-1b from monocytes stimulated by ATP). |
724424-43-5 |
DC20881 |
CE-245677
CE-245677 is a potent, selective, orally active, dual Tie2/Trk kinase inhibitor with IC50 of 4.7 nM, 1 nM for Tie2 and TrkA/B, respectively. |
717899-97-3 |
DC20336 |
CE3F4
Featured
CE3F4 is a potent, noncompetitive EPAC1 inhibitor that blocks EPAC1-induced Rap1 activation both in cell-free systems and in intact cells and did not influence protein kinase A holoenzyme activity. |
143703-25-7 |
DC23912 |
Cecropin B
Cecropin B is an antimicrobial peptide with MICs(0.5 to 16 ug/ml) against Gramnegative strains. |
80451-05-4 |
DC20987 |
Cedazuridine
Featured
Cedazuridine (E7727) is a novel cytidine deaminase inhibitor, and a componet of ASTX727 for treatment of hematologic malignancies.. |
1141397-80-9 |
DCAPI1386 |
Cefdinir (Omnicef)
Cefdinir (Omnicef) |
91832-40-5 |
DC8686 |
Cefetamet pivoxil hydrochloride
Cefetamet pivoxil hydrochloride is an oral third generation cephalosporin antibiotic. |
111696-23-2 |
DC9358 |
Cefmenoxime (hydrochloride)
Cefmenoxime hydrochloride is a third-generation cephalosporin antibiotic. |
75738-58-8 |
DCAPI1038 |
Cefoselis sulfate
Cefoselis sulfate |
122841-12-7 |